Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous HIV-1 ApB DC Vaccine in HIV-1 Infection
NCT00510497Phase 2Completed
- Start
- Jul 2007
- Primary completion
- Sep 2012
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of autologous HIV-1 ApB DC vaccine in human immunodeficiency virus infection (HIV). Started Jul 2007; status: completed.
02
Drugs
autologous HIV-1 ApB DC vaccine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00510497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00510497.